Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Anhydrous enol oxaloacetate by MetVital for Fatigue: Likelihood of Approval
Anhydrous enol oxaloacetate is under clinical development by MetVital and currently in Phase II for Fatigue. According to GlobalData, Phase...
Data Insights
Anhydrous enol oxaloacetate by MetVital for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Anhydrous enol oxaloacetate is under clinical development by MetVital and currently in Phase I for Amyotrophic Lateral Sclerosis. According to...